SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-21-010215
Filing Date
2021-02-01
Accepted
2021-02-01 16:33:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm214855d3_sc13ga.htm SC 13G/A 52693
  Complete submission text file 0001104659-21-010215.txt   54348
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Subject) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82540 | Film No.: 21577136
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ROOMS 1102-3, 11/F, REGENT CENTRE 88 QUEEN'S ROAD, CENTRAL HONG KONG K3 999077
Business Address ROOMS 1102-3, 11/F, REGENT CENTRE 88 QUEEN'S ROAD, CENTRAL HONG KONG K3 999077 86-13022199999
Top Path Asia Ltd (Filed by) CIK: 0001744426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G/A